α-Galactosylceramide protects swine against influenza infection when administered as a vaccine adjuvant

Natural killer T (NKT) -cells activated with the glycolipid ligand α-galactosylceramide (α-GalCer) stimulate a wide array of immune responses with many promising immunotherapeutic applications, including the enhancement of vaccines against infectious diseases and cancer. In the current study, we eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Artiaga, Bianca L., Yang, Guan, Hackmann, Timothy J., Liu, Qinfang, Richt, Jürgen A., Salek-Ardakani, Shahram, Castleman, William L., Lednicky, John A., Driver, John P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804283/
https://www.ncbi.nlm.nih.gov/pubmed/27004737
http://dx.doi.org/10.1038/srep23593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804283/
https://www.ncbi.nlm.nih.gov/pubmed/27004737
http://dx.doi.org/10.1038/srep23593

Ejemplares similares